our Premium Content: News alerts, weekly reports and conference planners
GENE:
FCGRT (Fc Gamma Receptor And Transporter)
i
Other names: FCGRT, Fc Gamma Receptor And Transporter, Fc Fragment Of IgG Receptor And Transporter, Neonatal Fc Receptor, FCRN, Heavy Chain Of The Major Histocompatibility Complex Class I-Like Fc Receptor, Transmembrane Alpha Chain Of The Neonatal Receptor, Fc Fragment Of IgG Receptor Transporter Alpha, IgG Fc Fragment Receptor Transporter Alpha Chain, IgG Receptor FcRn Large Subunit P51, Alpha-Chain, FcRn, Major Histocompatibility Complex Class I-Like Fc Receptor, Immunoglobulin Receptor, Intestinal, Heavy Chain, Neonatal Fc-Receptor For Ig, FCRN Alpha-Chain, FcRn Alpha Chain, FcgammaRn
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
These genes were also found to be associated with tumor mutational burden (TMB) and microsatellite instability (MSI) scores. Our findings reveal how these genes contribute to CRC pathogenesis by modulating the immune microenvironment, providing important biomarkers and targets for the development of novel therapeutic strategies.
This model integrates hFcRn cDNA into the endogenous locus of the mouse Fcgrt gene, completely replacing native mouse FcRn (mFcRn) expression. The hiFcRn mouse model offers a more human-relevant platform for the preclinical evaluation of therapeutic antibodies and Fc-fusion proteins.
In these lines, the main viral receptor genes, including PVR, CXADR, CD55, ITGA2, SCARB2, ICAM1, and FCGRT, were knocked out using the CRISPR/Cas9 system. The panel of lines was validated on twelve different Enteroviruses types, providing a basis for studying the molecular mechanisms of enterovirus entry into cells, and for developing new therapeutic strains.
We also observed severe cachexia and decreased, instead of increased, baseline pembrolizumab clearance in the tumor-free cisplatin-induced cachexia model. We conclude cachexia phenotype coincides with altered antibody clearance, though tumor presence is neither sufficient nor necessary for elevated clearance in immunocompetent mice. Magnitude and direction of clearance alteration correlated with hepatic Fcgrt, suggesting changes in FcRn expression and/or recycling function may be partially responsible, though factors beyond FcRn also contribute to altered clearance in cachexia.
To the best of our knowledge, this study represents the initial assessment of FcRn expression in endometrioid EC samples. FcRn expression was significantly associated with the FIGO stage. Ishikawa cell line proliferation did not significantly change in response to decreased FcRn expression. Further studies are needed to elucidate FcRn expression in EC as a potential molecular parameter.
Molecular docking results revealed that 2'-FL interacted with the attachment receptor αβ and the internalisation receptor FCGRT and βM with an affinity of -2.14, -1.87, and -5.43 kcal/mol, respectively. This study lays the foundation for using 2'-FL as a food additive against CV-A9 infections.
Taken together, a novel prognostic model was developed based on the expression level of neutrophil-related genes. FCGRT served as a promising candidate biomarker for anti-cancer drug response, which may contribute to individualized prognostic prediction and may contribute to clinical decision-making.